Modulation of Brain Tumor Capillaries for Enhanced Drug Delivery Selectively to Brain Tumor
نویسندگان
چکیده
منابع مشابه
Modulation of brain tumor capillaries for enhanced drug delivery selectively to brain tumor.
BACKGROUND The blood-brain tumor barrier (BTB) significantly impedes delivery of most hydrophilic molecules to brain tumors. Several promising strategies, however, have been developed to overcome this problem. METHODS We discuss several drug delivery methods to brain tumor, including intracerebroventricular, convection enhanced delivery, BBB/BTB disruption, and BTB permeability modulation, wh...
متن کاملO 25: Immunotherapy for Brain Tumor
In 1890, Coley observed that cancer patients who developed infections had smaller tumors. From this, he developed Coley’s toxin and treated tumors with injections of infectious materials. In 1960s, Mahaley used monoclonal antibodies to treat central nervous system(CNS) tumors, that research and clinical investigations in brain tumor immunotherapy became a serious undertaking. ...
متن کاملBrain tumor-targeted drug delivery strategies
Despite the application of aggressive surgery, radiotherapy and chemotherapy in clinics, brain tumors are still a difficult health challenge due to their fast development and poor prognosis. Brain tumor-targeted drug delivery systems, which increase drug accumulation in the tumor region and reduce toxicity in normal brain and peripheral tissue, are a promising new approach to brain tumor treatm...
متن کاملAn overview of therapeutic approaches to brain tumor stem cells
Primary and secondary malignant central nervous system (CNS) tumors are devastating invasive tumors able to give rise to many kinds of differentiated tumor cells. Glioblastoma multiform (GBM), is the most malignant brain tumor, in which its growth and persistence depend on cancer stem cells with enhanced DNA damage repair program that also induces recurrence and resists current chemo- and radi...
متن کاملDrug Delivery to Brain Tumor: Challenges and Recent Developments
Drug delivery for brain tumors is a questionable subject which is the major barrier in treatment. Nowadays, a lot of proposals have been developed to increase the amount of intravascular drug reaching the tumor. All drugs have a common disadvantage, only a small amount of delivered drug actually reaches the tumor. The systemic toxicity is the main doselimiting factor. When we are given directly...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Cancer Control
سال: 2004
ISSN: 1073-2748,1073-2748
DOI: 10.1177/107327480401100304